RxDoctor Payments Data

John Butler, MD

Internal Medicine · Meadowbrook, PANPI 1629049606

Payments from drug & device makers

$1,253in general payments, 2019–2025

Across 71 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$239
  • Pfizer$179
  • AstraZeneca$160
  • AbbVie$134
  • Novartis$127
  • Merck$56
  • plus $357 from 12 others

What the payments were for

  • Food & beverage$1,247100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,253 in reported general payments places this provider in the 75th percentile of 5,705 internal medicine providers in Pennsylvania.

See all internal medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$158,937
Medicare patients
529
Services billed
1,409

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban190$195,327
JardianceEmpagliflozin111$138,410
JanuviaSitagliptin Phosphate70$93,095
OzempicSemaglutide40$51,397
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$43,451
JanumetSitagliptin Phos/Metformin Hcl44$40,485
Janumet XrSitagliptin Phos/Metformin Hcl22$30,615
AbrysvoRsv Vacc, Pref A And Pref B/Pf87$27,516
Spiriva RespimatTiotropium Bromide19$17,083
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$14,405
TrintellixVortioxetine Hydrobromide13$13,344
MounjaroTirzepatide13$12,366
TrulicityDulaglutide13$12,204
Atorvastatin Calcium731$11,834
Breo ElliptaFluticasone/Vilanterol23$9,872

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$179$222,843277 claims
MerckJanuvia, Janumet, Janumet Xr$56$164,194136 claims
Boehringer IngelheimJardiance, Spiriva Respimat$34$155,493130 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Shingrix$239$73,896107 claims
Novo NordiskOzempic$17$51,39740 claims
Lilly USA, LLCMounjaro, Trulicity$54$24,57126 claims
Astellas Pharma US IncMyrbetriq$29$8,10413 claims
AbbVieSynthroid$134$1,97346 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 5,705 internal medicine providers in Pennsylvania.

Other internal medicine in Meadowbrook

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →